Immune reconstitution inflammatory syndrome presenting as pericarditis and pericardial effusion

Cardiology

Volumn 110, Issue 2, 2008, Pages 142-144

  Rapose, Alwyn ^a,b   Sarvat, Bilal ^a   Sarria, Juan C ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

HIV; Immune reconstitution inflammatory syndrome; Pericardial effusion; Pericarditis; Tuberculosis

Indexed keywords

EFAVIRENZ; EMTRICITABINE; ETHAMBUTOL; IBUPROFEN; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TENOFOVIR;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LABORATORY TEST; PERICARDIAL EFFUSION; PERICARDITIS; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TUBERCULOSIS;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; PERICARDIAL EFFUSION; PERICARDITIS; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULOSIS;

EID: 43049124815     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110494     Document Type: Article

References (12)

1. Meya DB, McAdam KP: The TB pandemic: an old problem seeking new solutions. J Intern Med 2007;261:309-329.
2. Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC Jr, Hamill RJ: Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005;19:399-406.
3. Breton G, Duval X, Estellat C, Poaletti X, Bonnet D, Mvondo Mvondo D, Longuet P, Leport C, Vilde JL: Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis 2004;39:1709-1712.
4. Narita M, Ashkin D, Hollender ES, Pitchenik AE: Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998;158:157-161.
5. Rajeswaran G, Becker JL, Michailidis C, Pozniak AL, Padley SP: The radiology of IRIS (immune reconstitution inflammatory syndrome) in patients with mycobacterial tuberculosis and HIV co-infection: appearances in 11 patients. Clin Radiol 2006;61:833-843.
6. Wendel KA, Alwood KS, Gachuhi R, Chaisson RE, Bishai WR, Sterling TR: Paradoxical worsening of tuberculosis in HIV-infected persons. Chest 2001;120:193-197.
7. Manosuthi W, Kiertiburanakul S, Phoorisri T, Sungkanuparph S: Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy. J Infect 2006;53:357-363.
8. Crum-Cianflone NF: Immune reconstitution inflammatory syndromes: what's new (review)? AIDS Read 2006;16:199-206, 213, 216-217; discussion 214-217.
9. Lawn SD, Myer L, Bekker LG, Wood R: Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 2007;21:335-341.
10. Mayosi BM, Burgess LJ, Doubell AF: Tuberculous pericarditis. Circulation 2005;112:3608-3616.
11. Burgess LJ, Reuter H, Carstens ME, Taljaard JJ, Doubell AF: Cytokine production in patients with tuberculous pericarditis. Int J Tuberc Lung Dis 2002;6:439-446.
12. Reuter H, Burgess LJ, Carstens ME, Doubell AF: Characterization of the immunological features of tuberculous pericardial effusions in HIV positive and HIV negative patients in contrast with non-tuberculous effusions. Tuberculosis (Edinb) 2006;86:125-133.